Olfaction Disorders

Displaying 1 - 9 of 9CSV
Adilbay, D., Gonzales, J., Zazhytska, M., Demetrio de Souza Franca, P., Roberts, S., Viray, T. D., Artschwager, R., Patel, S., Kodra, A., Overdevest, J. B., Chow, C. Y., King, G. F., Jain, S. K., Ordonez, A. A., Carroll, L. S., Lomvardas, S., Reiner, T., & Pillarsetty, N. (2024). Noninvasive Diagnostic Method to Objectively Measure Olfaction and Diagnose Smell Disorders by a Molecularly Targeted Fluorescence Imaging Agent. Journal of Nuclear Medicine, 65(8), 1293–1300. https://doi.org/10.2967/jnumed.123.266123
Publication Date
Jacobson, P. T., Vilarello, B. J., Tervo, J. P., Waring, N. A., Gudis, D. A., Goldberg, T. E., Devanand, D. P., & Overdevest, J. B. (2024). Associations between olfactory dysfunction and cognition: a scoping review. Journal of Neurology, 271(3), 1170–1203. https://doi.org/10.1007/s00415-023-12057-7
Publication Date
Miller, J. E., Taylor‐Cousar, J. L., Overdevest, J. B., Khatiwada, A., Mace, J. C., Alt, J. A., Bodner, T. E., Chowdhury, N. I., DiMango, E. A., Eshaghian, P. H., Getz, A. E., Gudis, D. A., Han, E. J., Hwang, P. H., Keating, C. L., Khanwalkar, A., Kimple, A. J., Lee, J. T., Li, D., … Beswick, D. M. (2023). Determining the minimal clinically important difference for the questionnaire of olfactory disorders in people with cystic fibrosis and factors associated with improvement after highly effective modulator therapy. International Forum of Allergy & Rhinology, 14(6), 1079–1087. Portico. https://doi.org/10.1002/alr.23312
Publication Date
Tervo, J. P., DiMango, E., Gudis, D. A., Keating, C., Zhang, Y., Leu, C., Altman, K., Vilarello, B., Jacobson, P., & Overdevest, J. B. (2023). Olfaction, body mass index, and quality of life with cystic fibrosis combination therapy. International Forum of Allergy & Rhinology, 13(12), 2165–2171. Portico. https://doi.org/10.1002/alr.23209
Publication Date
Vilarello, B. J., Jacobson, P. T., Tervo, J. P., Gallagher, L. W., Caruana, F. F., Gary, J. B., Saak, T. M., Gudis, D. A., Joseph, P. V., Goldberg, T. E., Devanand, D. P., & Overdevest, J. B. (2023). BMI Increases in Individuals with COVID-19-Associated Olfactory Dysfunction. Nutrients, 15(21), 4538. https://doi.org/10.3390/nu15214538
Publication Date
Stein, E., Chern, A., Chen, H., Shiroma, E. J., Devanand, D. P., Gudis, D. A., & Overdevest, J. B. (2022). Association between social determinants of health and olfactory dysfunction in older adults: A population‐based analysis. International Forum of Allergy & Rhinology, 13(5), 910–923. Portico. https://doi.org/10.1002/alr.23088
Publication Date
Overdevest, J. B., Irace, A. L., Mazzanti, V., Oh, E. J., Joseph, P. V., Devanand, D. P., Bitan, Z. C., Hod, E. A., Gudis, D. A., & Chiuzan, C. (2022). Chemosensory deficits are best predictor of serologic response among individuals infected with SARS-CoV-2. PLOS ONE, 17(12), e0274611. https://doi.org/10.1371/journal.pone.0274611
Publication Date
Saunders-Pullman, R., Ortega, R. A., Wang, C., Raymond, D., Elango, S., Leaver, K., Urval, N., Katsnelson, V., Gerber, R., Swan, M., Shanker, V., Alcalay, R. N., Mirelman, A., Brumm, M. C., Mejia-Santana, H., Coffey, C. S., Marek, K., Ozelius, L. J., Giladi, N., … Bressman, S. B. (2022). Association of Olfactory Performance With Motor Decline and Age at Onset in People With Parkinson Disease and the LRRK2 G2019S Variant. Neurology, 99(8). https://doi.org/10.1212/wnl.0000000000200737
Publication Date
Kamath, V., Senjem, M. L., Spychalla, A. J., Chen, H., Palta, P., Mosley, T. H., Windham, B. G., Griswold, M., Knopman, D. S., Gottesman, R. F., Jack, C. R., Sharrett, A. R., & Schneider, A. L. C. (2022). The Neuroanatomic Correlates of Olfactory Identification Impairment in Healthy Older Adults and in Persons with Mild Cognitive Impairment. Journal of Alzheimer’s Disease, 89(1), 233–245. https://doi.org/10.3233/jad-220228
Publication Date